$Cassava Sciences (SAVA.US)$As Sava gets closer to finishing...
$Cassava Sciences (SAVA.US)$ As Sava gets closer to finishing Phase 3 trials, FDA has scrutinized and been more stringent on letting any other AD drug with Amyloid plaque removal or brain bleeding deaths. 1900 patients on SAVA trials have the new methods from SAVA with Protein repair that slows decline and improves mild Alzheimer's patients. This new approach is the Breakthrough because it actually works!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
73266409 : When is it ready for release?